Revolution Medicines Billion Market: Why the Valuation Makes Sense
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
A collection of Zero Based Budgeting plan examples illustrating typical allocations and outcomes to help you craft your own plan.
22,359 articlesA biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
Grayscale Investments disclosed on July 2, 2026 that its CFO for the Ethereum Staking Mini ETF is leaving after seven...
When a top executive sells shares, investors tune in. This article breaks down what a recent move by Ladder Capital's...
Two industry giants released mixed Q1 results, highlighting divergent paths for July. Lockheed Martin stays mission-f...
The annual Sun Valley meeting is pivoting from legacy media power to AI and software influence, signaling a new era f...
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
The first half of 2026 handed investors a harsh lesson on how fast sentiment can turn in ad tech. This article breaks...
Ripple’s top executives discussed shutting down the firm after the SEC sued in 2020, a step that would have redirecte...
Palantir Technologies stock popped today on an earnings-tease event, not a full report. This article explains the dri...
CoreWeave’s stock suffers another long selloff as investors weigh debt exposure against growth in the AI cloud market...
Lucid Group sparked a sharp rally after the CEO denied bankruptcy rumors and take-private chatter. This article break...
NVIDIA, under Jensen Huang, has built more than chips—it's crafted an AI compute ecosystem. This article explains why...